Evidence map›Paper›PMID 40678872›Full record

ArticleBiotechnology and bioengineering2025

Scalable, High-Density Expansion of Human Mesenchymal Stem Cells on Microcarriers Using the Bach Impeller in Stirred-Tank Reactors.

Tom A Wyrobnik, Laia Miranda, Alan Lam, Steve Oh, Andrea Ducci, Martina Micheletti

Abstract read
In one paragraph

Article in Biotechnology and bioengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tom A WyrobnikDepartment of Biochemical Engineering, UCL, London, UK.ORCID https://orcid.org/0000-0001-9580-1705
Laia MirandaDepartment of Biochemical Engineering, UCL, London, UK.ORCID https://orcid.org/0000-0001-6414-2233
Alan LamBioprocessing Technology Institute, A*STAR, Singapore, Singapore.ORCID https://orcid.org/0000-0001-6831-9518
Steve OhBioprocessing Technology Institute, A*STAR, Singapore, Singapore.ORCID https://orcid.org/0000-0003-1463-8542
Andrea DucciDepartment of Mechanical Engineering, UCL, London, UK.ORCID https://orcid.org/0000-0003-0198-9634
Martina MichelettiDepartment of Biochemical Engineering, UCL, London, UK.ORCID https://orcid.org/0000-0001-5147-0182

Funding

This study was partially funded by Cellmotions Inc. (Hamilton, Ontario, Canada) and received financial supports from Ludwig Ehrlich Studienwerk (Germany); A*STAR (Singapore); the University College London (UCL)-AstraZeneca Center of Excellence and the UKRI Engineering and Physical Sciences Research Council (EPSRC) CDT Bioprocess Engineering Leadership (Grant reference: EP/S021868/1).
6 · The paper itself

Abstract

This paper describes the results of process developmental experiments to achieve higher cell densities in the manufacturing of hMSCs using the novel Bach impeller in a stirred-tank bioreactor. Engineering experiments have previously shown that the Bach impeller represents an efficient mixing device that suspends particles in fluids at low power inputs. To assess the impeller during biological experiments, the growth performance of Wharton Jelly (WJ)-hMSCs in a 1 L STR equipped with the Bach impeller was evaluated at a variety of culture conditions. The cells attached to Cytodex 1 microcarriers at a concentration of 5.6 g/L and were cultured for 5-7 days. The growth phase was carried out at varying impeller speeds

Indexed as

BioreactorsCell Culture TechniquesMesenchymal Stem CellsCell CountCell ProliferationCells, CulturedCell SurvivalHumansbioprocessingengineering characterizationmesenchymal stem cellsmicrocarriersstirred‐tank reactors

Identifiers

PMID40678872
PMCPMC12417783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.